Related references
Note: Only part of the references are listed.Histone deacetylase inhibitors: an overview of the clinical studies in solid tumors
Marije Slingerland et al.
ANTI-CANCER DRUGS (2014)
Identification of a cytoplasmic linker protein as a potential target for neovascularization
Songbo Xie et al.
ATHEROSCLEROSIS (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Identification of a Role for the PI3K/AKT/mTOR Signaling Pathway in Innate Immune Cells
Songbo Xie et al.
PLOS ONE (2014)
Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest
Jian Fan et al.
TUMOR BIOLOGY (2014)
Histone Deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1
Jeyran Shahbazi et al.
ONCOTARGET (2014)
Microtubule-Associated Protein Mdp3 Promotes Breast Cancer Growth and Metastasis
Tala et al.
THERANOSTICS (2014)
Microtubule Stabilization by Mdp3 Is Partially Attributed to Its Modulation of HDAC6 in Addition to Its Association with Tubulin and Microtubules
Tala et al.
PLOS ONE (2014)
Panobinostat in lymphoid and myeloid malignancies
Amit Khot et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Inhibition of HDAC6 Deacetylase Activity Increases Its Binding with Microtubules and Suppresses Microtubule Dynamic Instability in MCF-7 Cells
Jayant Asthana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Burkitt Lymphoma: beyond discoveries
Sam M. Mbulaiteye
INFECTIOUS AGENTS AND CANCER (2013)
Nucleation and Transport Organize Microtubules in Metaphase Spindles
Jan Brugues et al.
CELL (2012)
A novel GRK2/HDAC6 interaction modulates cell spreading and motility
Vanesa Lafarga et al.
EMBO JOURNAL (2012)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz et al.
NATURE (2012)
Ror2 Enhances Polarity and Directional Migration of Primordial Germ Cells
Diana J. Laird et al.
PLOS GENETICS (2011)
Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner
Dengwen Li et al.
PROTEIN & CELL (2011)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Targeting histone deacetylases for the treatment of disease
M. W. Lawless et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration
Udai Bhan Pandey et al.
AUTOPHAGY (2007)
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia:: a prospective study
Lionel Galicier et al.
BLOOD (2007)
HDAC6 modulates cell motility by altering the acetylation level of cortactin
Xiaohong Zhang et al.
MOLECULAR CELL (2007)
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor
JJ Kovacs et al.
MOLECULAR CELL (2005)
Histone deacetylase inhibitors and cancer: from cell biology to the clinic
H Hess-Stumpp
EUROPEAN JOURNAL OF CELL BIOLOGY (2005)
Shear stress-induced endothelial cell polarization is mediated by Rho and Rac but not Cdc42 or PI 3-kinases
B Wojciak-Stothard et al.
JOURNAL OF CELL BIOLOGY (2003)
Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation
SJ Haggarty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
HDAC6 is a microtubule-associated deacetylase
C Hubbert et al.
NATURE (2002)
Share Paper
